Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (Text with EEA relevance. )
Commission Delegated Regulation (EU) 2017/698of 3 February 2017amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products(Text with EEA relevance) THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1. and in particular Article 89(1) thereof,Whereas:(1)Commission Delegated Regulation (EU) No 1062/2014Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 (OJ L 294, 10.10.2014, p. 1). sets out, in its Annex II, an exhaustive list of existing active substances/product-type combinations included in the programme of review of existing biocidal active substances on 4 August 2014.(2)According to Article 14(3) of Delegated Regulation (EU) No 1062/2014, any person could have notified a substance/product-type combination included in part 2 of Annex II thereto within 12 months from the entry into force of that Regulation. Since that deadline has passed, part 2 of Annex II and Article 14(3) of that Regulation have become obsolete and Commission Implementing Decision (EU) 2016/1950Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 300, 8.11.2016, p. 14). has been taken not approving these substance/product type combinations.(3)Substance/product-type combinations notified pursuant to Article 14(3) and found compliant with Article 17(2) of Delegated Regulation (EU) No 1062/2014 should be included in part 1 of Annex II to that Regulation and removed from part 2 of that Annex.(4)According to Article 16(4) of Delegated Regulation (EU) No 1062/2014, an invitation was published where any person with an interest could notify the relevant active substance/product-type combination(s). One notification pursuant to Article 16(5) of Delegated Regulation (EU) No 1062/2014 and concerning dialuminium chloride pentahydroxide for use in product-type 2, was made before the deadline and was found compliant with Article 17(2) of Delegated Regulation (EU) No 1062/2014. Therefore this substance/product-type combination has to be included in part 1 of Annex II to that Regulation.(5)The Evaluating Competent Authority should be appointed pursuant to Article 81 of Regulation (EU) No 528/2012 for the active substance/product-type combinations mentioned in recital 3 and 4.(6)Active substance/product-type combinations for which a decision of approval or non-approval has been adopted since 4 August 2014 are no longer in the review programme, and therefore shall no longer be referred to in part 1 of Annex II to Delegated Regulation (EU) No 1062/2014.(7)The substance/product-type combinations listed in part 2 of Annex II to Delegated Regulation (EU) No 1062/2014 that were not notified pursuant to Article 14(3) of the Review Regulation should be removed from part 2 of that Annex. Part 2 of that Annex therefore becomes obsolete and should be removed.(8)Consequently, part 1 of Annex II to Delegated Regulation (EU) No 1062/2014 should become Annex II as it is the only remaining part in Annex II and references to Article 14(3) and part 1 of Annex II need to be removed.(9)Delegated Regulation (EU) No 1062/2014 should therefore be amended accordingly,HAS ADOPTED THIS REGULATION:
Article 1Delegated Regulation (EU) No 1062/2014 is amended as follows:(1)In Article 14, paragraph 3 is deleted.(2)Article 17 is amended as follows:(a)paragraph 1 is replaced by the following:"1.Notifications pursuant to Article 14(2) or Article 16(5) shall be made to the Agency through the Register."(b)in paragraph 7, point (a) is replaced by the following:"(a)where the notification has been submitted pursuant to Article 14(2), update the information in the Register with respect to the identity of the participant and, where relevant, of the substance;".(3)In Article 20 points (b) and (c) are replaced by the following:"(b)where no person has submitted a notification within the time limits provided for by Article 14(2) of this Regulation, or where such a notification has been submitted and rejected pursuant to Article 17(4) or Article 17(5) thereof;(c)where a notification has been submitted within the time limits provided for by Article 14(2) of this Regulation and has been found compliant pursuant to Article 17(5) thereof, but the substance identity in the notification only covers part of the existing identity in Annex II to this Regulation.".(4)Annex II is replaced by the text set out in the Annex to this Regulation.
Article 2This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 3 February 2017.For the CommissionThe PresidentJean-Claude JunckerANNEX

""

ANNEX IISUBSTANCE/PRODUCT-TYPE COMBINATIONS INCLUDED IN THE REVIEW PROGRAMME ON 3 FEBRUARY 2017Active substance/product-type combinations supported on 3 February 2017 excluding any other nanomaterial than those explicitly mentioned in entries 1017, 1019 and 1023
Entry numberSubstance nameRapporteur Member StateEC numberCAS number123456789101112131718192122
1FormaldehydeDE200-001-850-00-0xxx
62-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether (Piperonyl butoxide/PBO)EL200-076-751-03-6x
9BronopolES200-143-052-51-7xxxxxx
36EthanolEL200-578-664-17-5xxx
37Formic acidBE200-579-164-18-6xxxxxxx
43Salicylic acidNL200-712-369-72-7xxx
45Propan-1-olDE200-746-971-23-8xxx
52Ethylene oxideN200-849-975-21-8x
60Citric acidBE201-069-177-92-9x
69Glycolic acidNL201-180-579-14-1xxx
70Peracetic acidFI201-186-879-21-0xx
71L-(+)-lactic acidDE201-196-279-33-4xxxx
79(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone)UK201-501-983-79-4x
85SymcloseneUK201-782-887-90-1xxxxxx
92Biphenyl-2-olES201-993-590-43-7xxx
113Cinnamaldehyde/3-phenyl-propen-2-al (Cinnamic aldehyde)UK203-213-9104-55-2x
117GeraniolFR203-377-1106-24-1xx
122GlyoxalFR203-474-9107-22-2xxx
133Hexa-2,4-dienoic acid (Sorbic acid)DE203-768-7110-44-1x
154Clorophene (Chlorophene)N204-385-8120-32-1xx
1712-PhenoxyethanolUK204-589-7122-99-6xxxxx
172Cetylpyridinium chlorideUK204-593-9123-03-5x
179Carbon dioxideFR204-696-9124-38-9x
180Sodium dimethylarsinate (Sodium Cacodylate)PT204-708-2124-65-2x
185Tosylchloramide sodium (Tosylchloramide sodium — Chloramin T)ES204-854-7127-65-1xxxx
187Potassium dimethyldithiocarbamateUK204-875-1128-03-0xxx
188Sodium dimethyldithiocarbamateUK204-876-7128-04-1xxx
195Sodium 2-biphenylateES205-055-6132-27-4xxxxxxxxx
206ThiramBE205-286-2137-26-8x
210Metam-sodiumBE205-293-0137-42-8xx
2272-thiazol-4-yl-1H-benzoimidazole (Thiabendazole)ES205-725-8148-79-8xxx
235DiuronDK206-354-4330-54-1xx
239CyanamideDE206-992-3420-04-2xx
253Tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (Dazomet)BE208-576-7533-74-4xx
283TerbutrynSK212-950-5886-50-0xxx
288N-(Dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid)UK214-118-71085-98-9xx
292(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin)DE214-619-01166-46-7x
321MonolinuronUK217-129-51746-81-2x
330N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine)PT219-145-82372-82-9xxxxxxxx
3362,2′-dithiobis[N-methylbenzamide] (DTBMA)PL219-768-52527-58-4x
3391,2-benzisothiazol-3(2H)-one (BIT)ES220-120-92634-33-5xxxxxx
3412-methyl-2H-isothiazol-3-one (MIT)SI220-239-62682-20-4xxx
346Sodium dichloroisocyanurate dihydrateUK220-767-751580-86-0xxxxxx
345Troclosene sodiumUK220-767-72893-78-9xxxxxx
348Mecetronium ethyl sulphate (MES)PL221-106-53006-10-8x
359(ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm))PL222-720-63586-55-8xxxxx
365Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione)SE223-296-53811-73-2xxxxxxx
368Methenamine 3-chloroallylochloride (CTAC)PL223-805-04080-31-3xxx
3772,2′,2′-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol (HHT)PL225-208-04719-04-4xxxx
382Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD)ES226-408-05395-50-6xxxxx
392Methylene dithiocyanateFR228-652-36317-18-6x
3931,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH)PL229-222-86440-58-0xx
397Didecyldimethylammonium chloride (DDAC)IT230-525-27173-51-5xxxxxxxx
401SilverSE231-131-37440-22-4xxxxx
1023Silver, as a nanomaterialSE231-131-37440-22-4xxx
405Sulphur dioxideDE231-195-27446-09-5x
424Sodium bromideNL231-599-97647-15-6xxx
432Sodium hypochloriteIT231-668-37681-52-9xxxxxxx
434TetramethrinDE231-711-67696-12-0x
439Hydrogen peroxideFI231-765-07722-84-1xx
4447a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO)PL231-810-47747-35-5xx
450Silver nitrateSE231-853-97761-88-8x
453Disodium peroxodisulphate/Sodium persulphatePT231-892-17775-27-1x
455Calcium hypochloriteIT231-908-77778-54-3xxxxx
457ChlorineIT231-959-57782-50-5xxx
458Ammonium sulphateUK231-984-17783-20-2xx
1016Silver chlorideSE232-033-37783-90-6xxxxxxx
473Pyrethrins and PyrethroidsES232-319-88003-34-7xx
491Chlorine dioxidePT233-162-810049-04-4xxxxxx
4942,2-dibromo-2-cyanoacetamide (DBNPA)DK233-539-710222-01-2xxxxxx
501CarbendazimDE234-232-010605-21-7xxx
1022Dialuminium chloride pentahydroxideNL234-933-112042-91-0x
515Ammonium bromideSE235-183-812124-97-9xx
522Pyrithione zinc (Zinc pyrithione)SE236-671-313463-41-7xxxxxx
524Dodecylguanidine monohydrochlorideES237-030-013590-97-1xx
526Potassium 2-biphenylateES237-243-913707-65-8xxxx
529Bromine chlorideNL237-601-413863-41-7x
531(benzyloxy)methanolUK238-588-814548-60-8xx
541Sodium p-chloro-m-cresolateFR239-825-815733-22-9xxxxxx
550D-gluconic acid, compound with N,N′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) (CHDG)PT242-354-018472-51-0xxx
554p-[(diiodomethyl)sulphonyl]tolueneUK243-468-320018-09-1xxxx
559(benzothiazol-2-ylthio)methyl thiocyanate (TCMTB)N244-445-021564-17-0xx
5622-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin)EL245-387-923031-36-9x
563Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate)DE246-376-124634-61-5x
566.alpha.,.alpha.′,.alpha.′-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT)AT246-764-025254-50-6xxxx
5712-octyl-2H-isothiazol-3-one (OIT)UK247-761-726530-20-1xxxxxx
577Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chlorideES248-595-827668-52-6xxx
588Bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH/Bromochlorodimethylhydantoin)NL251-171-532718-18-6xxx
5903-(4-isopropylphenyl)-1,1-dimethylurea/IsoproturonDE251-835-434123-59-6xx
5971-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)DE252-615-035554-44-0x
599S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate (Azamethiphos)UK252-626-035575-96-3x
606.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Cyphenothrin)EL254-484-539515-40-7x
608Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloridePL255-451-841591-87-1x
609Mixture of cis- and trans-p-menthane-3,8 diol (Citriodiol)UK255-953-742822-86-6x
614(RS)-α-cyano-3phenoxybenzyl-(1RS)- cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin)BE257-842-952315-07-8x
6181-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin)BE259-154-454406-48-3x
6193-iodo-2-propynylbutylcarbamate (IPBC)DK259-627-555406-53-6xxx
620Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS)MT259-709-055566-30-8xxxx
6484,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro- 2-octyl-2H- isothiazol-3-one (DCOIT))N264-843-864359-81-5xxxx
6563,3′-methylenebis[5-methyloxazolidine] (Oxazolidin/MBO)AT266-235-866204-44-2xxxxx
667Alkyl (C12-18) dimethylbenzyl ammonium chloride (ADBAC (C12-18))IT269-919-468391-01-5xxxxxxxx
671Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16))IT270-325-268424-85-1xxxxxxxx
673Didecyldimethylammonium chloride (DDAC (C8-10))IT270-331-568424-95-3xxxxxxxxx
690Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) (ADBAS)MT273-545-768989-01-5xx
691Sodium N-(hydroxymethyl)glycinateAT274-357-870161-44-3x
692Amines, C10-16-alkyldimethyl, N-oxidesPT274-687-270592-80-2x
693Pentapotassium bis(peroxymonosulphate) bis(sulphate)SI274-778-770693-62-8xxxx
701Magnesium monoperoxyphthalate hexahydrate (MMPP)PL279-013-084665-66-7x
1015Margosa extractDE283-644-784696-25-3x
1024Margosa extract from cold-pressed oil of the kernels of Azadirachta Indica extracted with super-critical carbon dioxideDE283-644-784696-25-3x
724Alkyl (C12-C14) dimethylbenzylammonium chloride (ADBAC (C12-C14))IT287-089-185409-22-9xxxxxxxx
725Alkyl (C12-C14) dimethyl(ethylbenzyl)ammonium chloride (ADEBAC (C12-C14))IT287-090-785409-23-0xxxxxxxx
731Chrysanthemum cinerariaefolium, ext.ES289-699-389997-63-7x
744Lavender, Lavandula hybrida, ext./Lavandin oilPT294-470-691722-69-9x
779Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin)DE403-950-8164907-72-6xx
7856-(phthalimido)peroxyhexanoic acid (PAP)IT410-850-8128275-31-0xxxx
7912-butyl-benzo[d]isothiazol-3-one (BBIT)CZ420-590-74299-07-4xxxxx
792Tetrachlorodecaoxide complex (TCDO)DE420-970-292047-76-2xxx
811Silver sodium hydrogen zirconium phosphateSE422-570-3265647-11-8xxxxx
794sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine (Icaridine)DK423-210-8119515-38-7x
797cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC)PL426-020-351229-78-8xx
800[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate (Imiprothrin)UK428-790-672963-72-5x
807(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin)DE433-460-1210880-92-5
952Bacillus sphaericus other than Bacillus sphaericus 2362, strain ABTS-1743ITMicro-organism143447-72-7x
955Bacillus thuringiensis subsp.israelensis Serotype H14, other than strain AM65-52 and other than strain SA3AITMicro-organismNot applicablex
957Bacillus subtilisDEMicro-organismNot applicablex
939Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situSKMixtureNot applicablexxxx
813Peroxyoctanoic acidFRNot applicable33734-57-5xxx
1014Silver zeoliteSENot applicableNot applicablexxxxx
152Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH)NLNot availableNot availablex
459Reaction mass of titanium dioxide and silver chlorideSENot availableNot availablexxxxxxx
777Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH)NLNot availableNot availablex
810Silver phosphate glassSENot available308069-39-8xxx
824Silver zinc zeoliteSENot available130328-20-0xxxxx
1013Silver copper zeoliteSENot available130328-19-7xxxxx
1017Silver adsorbed on silicon dioxide (as a nanomaterial in the form of a stable aggregate with primary particles in the nanoscale)SENot availableNot availablex
1019Silicon dioxide (as a nanomaterial formed by aggregates and agglomerates)FRNot available68909-20-6x
831Silicium dioxide (Silicium dioxide/Kieselguhr)FRPlant protection product61790-53-2x
854(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-Allethrin)DEPlant protection product231937-89-6x
855(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin)DEPlant protection product260359-57-7x
848N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide (Acetamiprid)BEPlant protection product160430-64-8x
835Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate (Esfenvalerate)PTPlant protection product66230-04-4x
8434-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr)PTPlant protection product122453-73-0x
859Polymer of N-Methylmethanamine (Einecs 204-697-4 with (chloromethyl)oxirane (Einecs 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer)HUPolymer25988-97-0xx
863Monohydro chloride of polymer of N,N″-1,6-hexanediylbis[N′-cyanoguanidine] (Einecs 240-032-4) and hexamethylenediamine (Einecs 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) (PHMB)FRPolymer27083-27-8/32289-58-0x
868Poly(hexamethylenebiguanide)FRPolymer91403-50-8xxxxxxxx
869Poly(oxy-1,2-ethanediyl),.alpha.-[2-(didecylmethylammonio)ethyl]-.omega.-hydroxy-, propanoate (salt) (Bardap 26)ITPolymer94667-33-1xxx
872N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine)ELPolymer214710-34-6x